{"id":597649,"title":"Health Canada and CADTH launch initiative to provide early parallel scientific advice: Notice to industry - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-21","captureTimestamp":"2026-02-21T04:53:20.213000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/notice-early-panel-scientific-advice.html","snippet":"Notice to Industry: Health Canada and CADTH launch new initiative to provide early parallel scientific advice Improving Access to Medicines Health Canada's Regulatory Review of Drugs and Devices (R2D2) initiative aims to provide more timely access to medicines for Canadians.…","rawSnapshotUrl":"/api/snapshots/raw/597649","browseUrl":"https://replay.healtharchive.ca/job-6/20260221045320/https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/notice-early-panel-scientific-advice.html#ha_snapshot=597649","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}